A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/137 (2006.01) A61K 31/381 (2006.01) A61K 31/397 (2006.01) A61K 31/661 (2006.01) A61P 31/14 (2006.01)
Patent
CA 2592883
S1P receptor agonists are useful for the treatment of hepatitis C or chronic hepatitis C (HCV).
La présente invention décrit des agonistes du récepteur S1P qui sont utiles dans le traitement de l'hépatite C ou de l'hépatite C chronique (VHC).
Brinkmann Volker
Feutren Gilles
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Treatment of hcv disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of hcv disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hcv disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1621819